Skip to main content

Advertisement

SpringerLink
Log in

Update on neurosyphilis

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Neurosyphilis literally means syphilitic infection of the central nervous system, but it is often referred to incorrectly as “tertiary syphilis.” Neurosyphilis can occur at any time in the course of syphilis, even in the earliest, primary, stage. Early forms of neurosyphilis primarily affect the meninges, cerebrospinal fluid, and cerebral or spinal cord vasculature. Late forms of neurosyphilis primarily affect the brain and spinal cord parenchyma. Uveitis and hearing loss related to syphilis are most common in early syphilis and may be accompanied by early neurosyphilis. The treatment for syphilis-related eye disease and hearing loss is the same as the treatment for neurosyphilis. Neurosyphilis is more commonly seen in patients infected with HIV, and much of the recent literature pertains to this risk group. This article provides a critical review of recent literature on the diagnosis, clinical findings, risk factors, and management of neurosyphilis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lukehart SA, Hook EW III, Baker-Zander SA, et al.: Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988, 109:855–862.

    PubMed  CAS  Google Scholar 

  2. Wharton M, Chorba TL, Vogt RL, et al.: Case definitions for public health surveillance. MMWR Recomm Rep 1990, 39:1–43.

    PubMed  CAS  Google Scholar 

  3. Marra CM, Maxwell CL, Collier AC, et al.: Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. BMC Infect Dis 2007, 7:37.

    Article  PubMed  Google Scholar 

  4. Marra CM, Maxwell CL, Smith SL, et al.: Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004, 189:369–376.

    Article  PubMed  Google Scholar 

  5. Ghanem KG, Moore RD, Rompalo AM, et al.: Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 2008, 22:1145–1151.

    Article  PubMed  Google Scholar 

  6. Timmermans M, Carr J: Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry 2004, 75:1727–1730.

    Article  PubMed  CAS  Google Scholar 

  7. Hooshmand H, Escobar MR, Kopf SW: Neurosyphilis. A study of 241 patients. JAMA 1972, 219:726–729.

    Article  PubMed  CAS  Google Scholar 

  8. Castro R, Prieto ES, da Luz Martins Pereira F: Nontreponemal tests in the diagnosis of neurosyphilis: an evaluation of the Venereal Disease Research Laboratory (VDRL) and the Rapid Plasma Reagin (RPR) tests. J Clin Lab Anal 2008, 22:257–261.

    Article  PubMed  Google Scholar 

  9. Larsen SA, Hambie EA, Wobig GH, Kennedy EJ: Cerebrospinal fluid serologic test for syphilis: treponemal and nontreponemal tests. In Advances in Sexually Transmitted Diseases. Edited by Morisset R, Kurstak E. Utrecht, The Netherlands: VNU Science Press; 1985:157–162.

    Google Scholar 

  10. Davis LE, Schmitt JW: Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol 1989, 25:50–55.

    Article  PubMed  CAS  Google Scholar 

  11. Marra CM, Critchlow CW, Hook EW III, et al.: Cerebrospinal fluid treponemal antibodies in untreated early syphilis. Arch Neurol 1995, 52:68–72.

    PubMed  CAS  Google Scholar 

  12. Marra CM, Tantalo LC, Maxwell CL, et al.: Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIVinfected individuals. Neurology 2004, 63:85–88.

    PubMed  CAS  Google Scholar 

  13. Workowski KA, Berman SM: Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006, 55:1–94.

    PubMed  Google Scholar 

  14. Symptomatic early neurosyphilis among HIV-positive men who have sex with men-four cities, United States, January 2002–June 2004. MMWR Morb Mortal Wkly Rep 2007, 56:625–628.

  15. Hughes GB, Rutherford I: Predictive value of serologic tests for syphilis in otology. Ann Otol Rhinol Laryngol 1986, 95:250–259.

    PubMed  CAS  Google Scholar 

  16. Becker GD: Late syphilitic hearing loss: a diagnostic and therapeutic dilemma. Laryngoscope 1979, 89:1273–1288.

    PubMed  CAS  Google Scholar 

  17. Yimtae K, Srirompotong S, Lertsukprasert K: Otosyphilis: a review of 85 cases. Otolaryngol Head Neck Surg 2007, 136:67–71.

    Article  PubMed  Google Scholar 

  18. Jeans AR, Wilkins EG, Bonington A: Sensorineural hearing loss due to secondary syphilis. Int J STD AIDS 2008, 19:355–356.

    Article  PubMed  CAS  Google Scholar 

  19. Klemm E, Wollina U: Otosyphilis: report on six cases. J Eur Acad Dermatol Venereol 2004, 18:429–434.

    Article  PubMed  CAS  Google Scholar 

  20. Mishra S, Walmsley SL, Loutfy MR, et al.: Otosyphilis in HIV-coinfected individuals: a case series from Toronto, Canada. AIDS Patient Care STDS 2008, 22:213–219.

    Article  PubMed  Google Scholar 

  21. Song JJ, Lee HM, Chae SW, Hwang SJ: Bilateral otosyphilis in a patient with HIV infection. Eur Arch Otorhinolaryngol 2005, 262:972–974.

    Article  PubMed  Google Scholar 

  22. Aldave AJ, King JA, Cunningham ET Jr: Ocular syphilis. Curr Opin Ophthalmol 2001, 12:433–441.

    Article  PubMed  CAS  Google Scholar 

  23. Ormerod LD, Puklin JE, Sobel JD: Syphilitic posterior uveitis: correlative findings and significance. Clin Infect Dis 2001, 32:1661–1673.

    Article  PubMed  CAS  Google Scholar 

  24. Zwink FB, Dunlop EM: Clinically silent anterior uveitis in secondary syphilis. Trans Ophthalmol Soc U K 1976, 96:148–150.

    PubMed  CAS  Google Scholar 

  25. Kitson MT, Yong MK, Hoy JF: Ocular syphilis: are we seeing all there is to see? Med J Aust 2008, 189:411.

    PubMed  Google Scholar 

  26. Joseph A, Rogers S, Browning A, et al.: Syphilitic acute posterior placoid chorioretinitis in nonimmuno-compromised patients. Eye 2007, 21:1114–1119.

    Article  PubMed  CAS  Google Scholar 

  27. Chao JR, Khurana RN, Fawzi AA, et al.: Syphilis: reemergence of an old adversary. Ophthalmology 2006, 113:2074–2079.

    Article  PubMed  Google Scholar 

  28. Doris JP, Saha K, Jones NP, Sukthankar A: Ocular syphilis: the new epidemic. Eye 2006, 20:703–705.

    Article  PubMed  CAS  Google Scholar 

  29. Parc CE, Chahed S, Patel SV, Salmon-Ceron D: Manifestations and treatment of ocular syphilis during an epidemic in France. Sex Transm Dis 2007, 34:553–556.

    Article  PubMed  Google Scholar 

  30. Balba GP, Kumar PN, James AN, et al.: Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy. Am J Med 2006, 119:448 e21–5.

    Article  Google Scholar 

  31. Kiss S, Damico FM, Young LH: Ocular manifestations and treatment of syphilis. Semin Ophthalmol 2005, 20:161–167.

    Article  PubMed  Google Scholar 

  32. Zamani M, Garfinkel RA: Corticosteroid-induced modulation of acute syphilitic posterior placoid chorioretinitis. Am J Ophthalmol 2003, 135:891–894.

    Article  PubMed  Google Scholar 

  33. Erol N, Topbas S: Acute syphilitic posterior placoid chorioretinitis after an intravitreal triamcinolone acetonide injection. Acta Ophthalmol Scand 2006, 84:435.

    Article  PubMed  Google Scholar 

  34. Song JH, Hong YT, Kwon OW: Acute syphilitic posterior placoid chorioretinitis following intravitreal triamcinolone acetonide injection. Graefes Arch Clin Exp Ophthalmol 2008, 246:1775–1778.

    Article  PubMed  Google Scholar 

  35. Gordon SM, Eaton ME, George R, et al.: The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994, 331:1469–1473.

    Article  PubMed  CAS  Google Scholar 

  36. Fathilah J, Choo MM: The Jarisch-Herxheimer reaction in ocular syphilis. Med J Malaysia 2003, 58:437–439.

    PubMed  CAS  Google Scholar 

  37. Gurses C, Bilgic B, Topcular B, et al.: Clinical and magnetic resonance imaging findings of HIV-negative patients with neurosyphilis. J Neurol 2007, 254:368–374.

    Article  PubMed  Google Scholar 

  38. Noone ML, Sinha S, Taly AB, Chandrika S: Periodic lateralized epileptiform discharges in neurosyphilis. Epilepsia 2007, 48:390–393.

    Article  PubMed  Google Scholar 

  39. Chang YP, Lin RT, Liu CK, et al.: Neurosyphilis presenting with status epilepticus. Neurologist 2006, 12:314–317.

    Article  PubMed  Google Scholar 

  40. Bash S, Hathout GM, Cohen S: Mesiotemporal T2-weighted hyperintensity: neurosyphilis mimicking herpes encephalitis. AJNR Am J Neuroradiol 2001, 22:314–316.

    PubMed  CAS  Google Scholar 

  41. Szilak I, Marty F, Helft J, Soeiro R: Neurosyphilis presenting as herpes simplex encephalitis. Clin Infect Dis 2001, 32:1108–1109.

    Article  PubMed  CAS  Google Scholar 

  42. Marano E, Briganti F, Tortora F, et al.: Neurosyphilis with complex partial status epilepticus and mesiotemporal MRI abnormalities mimicking herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 2004, 75:833.

    Article  PubMed  CAS  Google Scholar 

  43. Lansberg MG, O’Brien MW, Norbash AM, et al.: MRI abnormalities associated with partial status epilepticus. Neurology 1999, 52:1021–1027.

    PubMed  CAS  Google Scholar 

  44. Hicdonmez T, Utku U, Turgut N, et al.: Reversible postictal MRI change mimicking structural lesion. Clin Neurol Neurosurg 2003, 105:288–290.

    Article  PubMed  Google Scholar 

  45. Polnikorn N, Witoonpanich R, Vorachit M, et al.: Penicillin concentrations in cerebrospinal fluid after different treatment regimens for syphilis. Br J Vener Dis 1980, 56:363–367.

    PubMed  CAS  Google Scholar 

  46. van der Valk PG, Kraai EJ, van Voorst Vader PC, et al.: Penicillin concentrations in cerebrospinal fluid (CSF) during repository treatment regimen for syphilis. Genitourin Med 1988, 64:223–225.

    PubMed  Google Scholar 

  47. Tramont EC: Persistence of Treponema pallidum following penicillin G therapy. Report of two cases. JAMA 1976, 236:2206–2207.

    Article  PubMed  CAS  Google Scholar 

  48. Berry CD, Hooton TM, Collier AC, Lukehart SA: Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987, 316:1587–1589.

    PubMed  CAS  Google Scholar 

  49. Walter T, Lebouche B, Miailhes P, et al.: Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients. Clin Infect Dis 2006, 43:787–790.

    Article  PubMed  CAS  Google Scholar 

  50. Richards BW, Hessburg TJ, Nussbaum JN: Recurrent syphilitic uveitis. N Engl J Med 1989, 320:62.

    PubMed  CAS  Google Scholar 

  51. Taylor MM, Aynalem G, Olea LM, et al.: A consequence of the syphilis epidemic among men who have sex with men (MSM): neurosyphilis in Los Angeles, 2001–2004. Sex Transm Dis 2008, 35:430–434.

    Article  PubMed  Google Scholar 

  52. Poliseli R, Vidal JE, Penalva De Oliveira AC, Hernandez AV: Neurosyphilis in HIV-infected patients: clinical manifestations, serum venereal disease research laboratory titers, and associated factors to symptomatic neurosyphilis. Sex Transm Dis 2008, 35:425–429.

    Article  PubMed  Google Scholar 

  53. Libois A, De Wit S, Poll B, et al.: HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007, 34:141–144.

    Article  PubMed  Google Scholar 

  54. Zetola NM, Klausner JD: Syphilis and HIV infection: an update. Clin Infect Dis 2007, 44:1222–1228.

    Article  PubMed  Google Scholar 

  55. Moore J: Studies in asymptomatic neurosyphilis II. The classification, treatment, and prognosis of early asymptomatic neurosyphilis. Bull Johns Hopkins Hosp 1922, 33:231–246.

    Google Scholar 

  56. Rolfs RT, Joesoef MR, Hendershot EF, et al.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997, 337:307–314.

    Article  PubMed  CAS  Google Scholar 

  57. Shann S, Wilson J: Treatment of neurosyphilis with ceftriaxone. Sex Transm Infect 2003, 79:415–416.

    Article  PubMed  CAS  Google Scholar 

  58. Dowell ME, Ross PG, Musher DM, et al.: Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992, 93:481–488.

    Article  PubMed  CAS  Google Scholar 

  59. Marra CM, Boutin P, McArthur JC, et al.: A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virusinfected individuals. Clin Infect Dis 2000, 30:540–544.

    Article  PubMed  CAS  Google Scholar 

  60. Marra CM, Maxwell CL, Tantalo L, et al.: Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis 2004, 38:1001–1006.

    Article  PubMed  Google Scholar 

  61. Marra CM, Maxwell CL, Tantalo LC, et al.: Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008, 47:893–899.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harborview Medical Center, University of Washington School of Medicine, Box 359775, 325 Ninth Avenue, Seattle, WA, 98104, USA

    Christina M. Marra

Authors
  1. Christina M. Marra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christina M. Marra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marra, C.M. Update on neurosyphilis. Curr Infect Dis Rep 11, 127–134 (2009). https://doi.org/10.1007/s11908-009-0019-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-009-0019-1

Keywords

Search

Navigation